Full-Life Technologies
PrivateLast Round
Series D
May 18, 2026
Total Funding Raised
$297.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Full-Life Technologies is a biotechnology company that develops and commercializes precision nuclear medicines and radionuclide-drug conjugates for cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Full-Life Technologies Comparables
Compare Full-Life Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ARTBIO | 85% | |
| Convergent Therapeutics | 84% | |
| Ratio Therapeutics Inc. | 84% | |
Full-Life Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 18, 2026 | ||||
| Debt | Sep 30, 2025 | ||||
| Series C | Sep 30, 2025 | ||||
| Debt | Jan 3, 2024 | ||||
| Series B | Jan 3, 2024 | ||||
Series A | May 26, 2022 |
Full-Life Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CD Capital Asset Management | Series A |
| Summer Capital | Series C, Series B |
| Guanghua Wutong Fund | Series B |
| Junson Capital | Series D, Series C, Series A, Series B |
| Lapam Capital | Series C |
| Yunion Health Investments | Series A |
| Sky9 Capital | Series D, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$110M round led by Vivo Capital.
- Apr 1, 2026
Job posting reveals development of c-MET assets.
Full-Life Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Full-Life Technologies's valuation, stock price, and market status.